Circulation
MARCH 19, 2025
The field of cardio-oncology has expanded over the past 2 decades to address the ever-increasing issues related to cardiovascular disease in patients with cancer and survivors. Circulation, Ahead of Print.
European Journal of Heart Failure
DECEMBER 20, 2023
Abstract Cardio-oncology is a rapidly growing field of cardiovascular (CV) medicine that has resulted from the continuously increasing clinical demand for specialized CV evaluation, prevention and management of patients suffering or surviving from malignant diseases.
DAIC
JUNE 19, 2024
Getty Images milla1cf Wed, 06/19/2024 - 20:54 June 19, 2024 — Modern therapies have extended the lives of many cancer patients; however, survivors often live with chronic health conditions, including cardiovascular disease. The new study was motivated by a need to fill that gap, Rao said. They found that exposure to PM2.5,
American College of Cardiology
NOVEMBER 22, 2024
Preventing, detecting and managing cancer therapy-related cardiovascular toxicity (CTR-CVT) is a clear objective during cancer treatment.
Medical Xpress - Cardiology
DECEMBER 13, 2024
The devastating news of a cancer diagnosis understandably makes doctors and patients focus on the cancer itself.
European Journal of Heart Failure
MARCH 11, 2025
Furthermore, it discusses how preclinical models have contributed to the provocative concept of heart failure being potentially tumorigenic and how the discovery of drugs with both anticancer and cardioprotective actions has revealed a common mechanistic basis for heart failure and cancer.
Frontiers in Cardiovascular Medicine
FEBRUARY 28, 2024
This is the first case series to shed light on the application of cangrelor in cancer patients needing to pause dual antiplatelet therapy for a range of medical interventions, marking it as a pioneering effort in this domain.
Expert insights. Personalized for you.
55 
Let's personalize your content